Yauhen Statsenko, Darya Smetanina, Roman Voitetskii, Gillian Lylian Simiyu, Mikalai Pazniak, Elena Likhorad, Aleh Pazniak, Pavel Beliakouski, Dmitri Abelski, Fatima Ismail, Klaus Neidl-Van Gorkom, Milos Ljubisavljevic
{"title":"Digital transformation of care for keratoconus patients: ML modeling structural outcomes of corneal collagen cross-linking.","authors":"Yauhen Statsenko, Darya Smetanina, Roman Voitetskii, Gillian Lylian Simiyu, Mikalai Pazniak, Elena Likhorad, Aleh Pazniak, Pavel Beliakouski, Dmitri Abelski, Fatima Ismail, Klaus Neidl-Van Gorkom, Milos Ljubisavljevic","doi":"10.3389/fmed.2025.1462653","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Structural outcomes of corneal collagen cross-linking (CXL) have not been thoroughly investigated. Clinical risk assessment would benefit from a reliable prognosis of postoperative minimal (MCT) and central corneal thickness (CCT).</p><p><strong>Objective: </strong>The objective of this study was to find a combination of diagnostic modalities and measurements that reliably reflect CXL efficiency in terms of corneal thickness.</p><p><strong>Methods: </strong>We retrospectively reviewed the medical histories of 107 patients (131 eyes) who underwent CXL. The dataset included preoperative examinations and follow-up results, which totalled 796 observations.</p><p><strong>Results: </strong>The postoperative changes in MCT are more pronounced, clinically relevant, and meaningful than in CCT. MCT should serve as the major clinical marker of corneal thinning after CXL. The cornea's potential to recover reduces in advanced keratoconus. A polynomial curve demonstrates the natural course of corneal remodeling. It includes thinning immediately after CXL and stabilization with partial recovery of corneal thickness over time. Baseline pachymetry data can adequately reflect the outcomes. Preoperative BAD and topographic indices <i>strongly</i> correlate with the outcomes. Keratometry and refractometry data exhibit <i>moderate</i> associations with postoperative corneal thickness. The models trained on a combination of top correlating features, clinical data, and time after intervention provide the most reliable prognosis.</p><p><strong>Conclusion: </strong>Risk assessment is accurate with multimodal preoperative diagnostics. A stratification system should take into account findings in different diagnostic modalities.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1462653"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12174071/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1462653","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Structural outcomes of corneal collagen cross-linking (CXL) have not been thoroughly investigated. Clinical risk assessment would benefit from a reliable prognosis of postoperative minimal (MCT) and central corneal thickness (CCT).
Objective: The objective of this study was to find a combination of diagnostic modalities and measurements that reliably reflect CXL efficiency in terms of corneal thickness.
Methods: We retrospectively reviewed the medical histories of 107 patients (131 eyes) who underwent CXL. The dataset included preoperative examinations and follow-up results, which totalled 796 observations.
Results: The postoperative changes in MCT are more pronounced, clinically relevant, and meaningful than in CCT. MCT should serve as the major clinical marker of corneal thinning after CXL. The cornea's potential to recover reduces in advanced keratoconus. A polynomial curve demonstrates the natural course of corneal remodeling. It includes thinning immediately after CXL and stabilization with partial recovery of corneal thickness over time. Baseline pachymetry data can adequately reflect the outcomes. Preoperative BAD and topographic indices strongly correlate with the outcomes. Keratometry and refractometry data exhibit moderate associations with postoperative corneal thickness. The models trained on a combination of top correlating features, clinical data, and time after intervention provide the most reliable prognosis.
Conclusion: Risk assessment is accurate with multimodal preoperative diagnostics. A stratification system should take into account findings in different diagnostic modalities.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world